BioLineRx Ltd. (BLRX) income statement
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.96−0.10 (-9.07%)
Close on Nov 20, 2026Market cap $4.19MP/E –Yield –
BioLineRx Ltd. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $4.19MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Gross margin | 80.5% | 68.0% | 23.1% | – | – | – | – | – | – | – | – | – |
| Operating margin | -871.8% | -70.5% | -1,035.3% | – | – | – | – | – | – | – | – | – |
| EBITDA margin | -827.5% | -56.5% | -1,006.5% | – | – | – | – | – | – | – | – | – |
| Free cash flow margin | -686.4% | -151.8% | -473.4% | – | – | – | – | – | – | – | – | – |
| Returns on capital | ||||||||||||
| Return on invested capital | -50.7% | -164.4% | -145.6% | -46.2% | -59.2% | -92.7% | -63.8% | -46.7% | -49.5% | -40.0% | – | – |
| Return on capital employed | -39.4% | -91.4% | -114.4% | -42.4% | -45.7% | -58.6% | -61.7% | -49.4% | -56.4% | -46.8% | – | – |
| Return on total capital | -45.0% | -119.0% | -144.6% | -47.3% | -51.6% | -74.9% | -71.8% | -53.8% | -57.3% | -47.0% | – | – |
| NOPAT | -$8.13M | -$16.12M | -$39.26M | -$23.03M | -$19.57M | -$18.11M | -$22.21M | -$20.23M | -$19.94M | -$13.05M | -$12.79M | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | -684.2% | -151.6% | -471.0% | – | – | – | – | – | – | – | – | – |
| FCF / OCF | 100.3% | 100.1% | 100.5% | 100.5% | 100.4% | 100.0% | 100.3% | 100.7% | 101.6% | 100.4% | 118.9% | – |
| FCF / EBITDA | 82.9% | 268.8% | 47.0% | 92.5% | 98.3% | 105.5% | 83.7% | 97.2% | 84.4% | 90.9% | 107.0% | – |
| Unlevered free cash flow | -$7.09M | -$36.72M | -$21.01M | -$24.67M | -$22.88M | -$21.92M | -$20.93M | -$23.99M | -$20.87M | -$14.55M | -$16.77M | – |
| Levered free cash flow | -$8.10M | -$43.93M | -$22.72M | -$26.37M | -$23.67M | -$23.21M | -$22.73M | -$24.37M | -$20.89M | -$14.57M | -$16.85M | – |
| Efficiency | ||||||||||||
| Asset turnover | 0.03 | 0.56 | 0.07 | 0.00 | 0.00 | – | – | – | – | – | – | – |
| Fixed asset turnover | 4.32 | 67.38 | 8.01 | 0.00 | 0.00 | – | – | – | – | – | – | – |
| Inventory turnover | 0.09 | 3.63 | 3.78 | – | – | – | – | – | – | – | – | – |
| Days inventory outstanding | 4,199.9 | 100.4 | 96.5 | – | – | – | – | – | – | – | – | – |
| CapEx to revenue | 2.1% | 0.18% | 2.4% | – | – | – | – | – | – | – | – | – |
| CapEx to OCF | -0.31% | -0.12% | -0.51% | -0.50% | -0.41% | -0.00% | -0.30% | -0.72% | -1.6% | -0.36% | -18.9% | – |
| CapEx to depreciation | 0.05 | 0.01 | 0.08 | 0.20 | 0.14 | 0.00 | 0.07 | 0.32 | 0.70 | 0.11 | 6.08 | – |
| Liquidity | ||||||||||||
| Current ratio | 1.95 | 1.76 | 1.10 | 4.87 | 5.91 | 2.15 | 2.36 | 4.74 | 7.49 | 9.86 | – | – |
| Quick ratio | 1.78 | 1.56 | 1.06 | 4.87 | 5.91 | 2.15 | 2.36 | 4.74 | 7.49 | 9.86 | – | – |
| Cash ratio | 0.27 | 0.68 | 0.10 | 0.99 | 1.34 | 1.58 | 0.44 | 0.50 | 0.76 | 0.67 | – | – |
| Working capital | $11.56M | $11.70M | $4.40M | $41.32M | $47.69M | $12.24M | $16.24M | $25.23M | $43.65M | $32.44M | – | – |
| Net current asset value | $6.12M | $1.66M | -$3.52M | $26.46M | $44.10M | -$2.38M | $8.02M | $17.07M | $42.29M | $32.19M | – | – |
| Leverage | ||||||||||||
| Total debt | $4.48M | $4.48M | $3.15M | $1.54M | $2.76M | $3.09M | $2.69M | $895.00K | $93.00K | $93.00K | – | – |
| Net debt | $1.23M | -$5.96M | -$1.11M | -$9.05M | -$10.23M | -$13.74M | -$2.61M | -$2.51M | -$5.02M | -$2.38M | – | – |
| Debt / Equity | 0.25 | 0.33 | 0.24 | 0.03 | 0.04 | 0.14 | 0.08 | 0.02 | 0.00 | 0.00 | – | – |
| Debt ratio | 10.9% | 11.5% | 4.9% | 2.0% | 3.4% | 6.5% | 5.0% | 1.6% | 0.15% | 0.24% | – | – |
| Assets to equity | 2.25 | 2.89 | 4.83 | 1.50 | 1.20 | 2.15 | 1.60 | 1.36 | 1.15 | 1.11 | – | – |
| Total debt / Capitalization | 19.8% | 25.0% | 19.2% | 2.9% | 3.9% | 12.3% | 7.5% | 2.1% | 0.18% | 0.26% | – | – |
| Net debt / EBITDA | -0.13 | 0.36 | 0.02 | 0.32 | 0.43 | 0.62 | 0.10 | 0.10 | 0.20 | 0.15 | – | – |
| Total debt / EBITDA | -0.46 | -0.27 | -0.07 | -0.05 | -0.11 | -0.14 | -0.10 | -0.04 | -0.00 | -0.01 | – | – |
| Cash flow to debt | -180.3% | -979.5% | -718.9% | -1,701.7% | -855.0% | -750.5% | -842.0% | -2,703.0% | -22,093.5% | -15,605.4% | – | – |
| Intangibles to total assets | 40.0% | 26.9% | 23.2% | 28.7% | 26.7% | 45.9% | 40.9% | 39.1% | 11.5% | 0.46% | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | -8.04 | -2.24 | -22.91 | -13.51 | -24.63 | -14.07 | -12.35 | -54.13 | -1,201.90 | -750.59 | -152.79 | – |
| EBITDA / Interest expense | -7.63 | -1.79 | -22.27 | -13.21 | -23.93 | -13.50 | -11.93 | -52.98 | -1,179.00 | -728.68 | -148.63 | – |
| (EBITDA − CapEx) / Interest expense | -7.65 | -1.80 | -22.33 | -13.27 | -24.03 | -13.50 | -11.96 | -53.35 | -1,195.10 | -731.05 | -173.94 | – |
| Per share | ||||||||||||
| Revenue per share | 0.0005 | 0.02 | 0.0050 | 0.00 | 0.00 | – | – | – | – | – | – | – |
| EPS (basic) | 0.00 | -0.01 | -0.06 | -0.03 | -0.04 | -0.12 | -0.17 | -0.21 | -0.27 | -0.28 | -0.28 | – |
| EPS (diluted) | 0.00 | -0.01 | -0.06 | -0.03 | -0.04 | -0.12 | -0.17 | -0.21 | -0.27 | -0.28 | -0.28 | – |
| Book value per share | 0.0074 | 0.01 | 0.01 | 0.07 | 0.10 | 0.09 | 0.23 | 0.38 | 0.59 | 0.62 | 0.93 | – |
| Tangible book value per share | 0.0007 | 0.0025 | -0.0017 | 0.04 | 0.07 | 0.0012 | 0.08 | 0.18 | 0.51 | 0.62 | 0.93 | – |
| Cash per share | 0.0013 | 0.0087 | 0.0044 | 0.01 | 0.02 | 0.07 | 0.04 | 0.03 | 0.06 | 0.04 | 0.11 | – |
| Operating cash flow per share | -0.0033 | -0.04 | -0.02 | -0.03 | -0.04 | -0.09 | -0.15 | -0.22 | -0.23 | -0.26 | -0.28 | – |
| Free cash flow per share | -0.0033 | -0.04 | -0.02 | -0.03 | -0.04 | -0.09 | -0.16 | -0.22 | -0.23 | -0.26 | -0.33 | – |
| CapEx per share | 0.0000 | 0.0000 | 0.0001 | 0.0002 | 0.0001 | 0.00 | 0.0005 | 0.0016 | 0.0038 | 0.0009 | 0.05 | – |
| Valuation at period end | ||||||||||||
| Market cap | $5.53M | $13.74M | $81.01M | $26.08M | $34.39M | $24.60M | $16.29M | $39.34M | $61.19M | $47.29M | – | – |
| Enterprise value | $2.82M | $14.78M | $73.98M | $13.09M | $20.26M | $21.94M | $13.71M | $33.65M | $58.82M | $41.75M | – | – |
| P/S | 4.7x | 0.5x | 16.9x | – | – | – | – | – | – | – | – | – |
| P/B | 0.3x | 1.0x | 6.1x | 0.5x | 0.5x | 1.1x | 0.5x | 1.0x | 1.2x | 1.4x | – | – |
| P/TBV | 3.0x | 4.6x | -49.7x | 0.9x | 0.7x | 77.8x | 1.4x | 2.0x | 1.3x | 1.4x | – | – |
| P/Gross profit | 5.8x | 0.7x | 73.1x | – | – | – | – | – | – | – | – | – |
| P/OCF | -0.7x | -0.3x | -3.6x | -1.0x | -1.5x | -1.1x | -0.7x | -1.6x | -3.0x | -3.3x | – | – |
| EV/Sales | 2.4x | 0.5x | 15.4x | – | – | – | – | – | – | – | – | – |
| EV/Gross profit | 3.0x | 0.8x | 66.8x | – | – | – | – | – | – | – | – | – |
| EV/OCF | -0.3x | -0.3x | -3.3x | -0.5x | -0.9x | -0.9x | -0.6x | -1.4x | -2.9x | -2.9x | – | – |
| FCF yield | -146.4% | -319.6% | -28.1% | -101.1% | -68.8% | -94.3% | -139.6% | -61.9% | -34.1% | -30.8% | – | – |
| Shareholder yield | ||||||||||||
| Debt paydown yield | -63.5% | -37.5% | 1.9% | -57.6% | 11.1% | 12.7% | 5.5% | 1.0% | 0.15% | – | – | – |
| Cost structure | ||||||||||||
| R&D to revenue | 685.8% | 31.6% | 260.8% | – | – | – | – | – | – | – | – | – |
| SG&A to revenue | 266.4% | 21.8% | 131.5% | – | – | – | – | – | – | – | – | – |
| Stock-based comp to revenue | 33.6% | 3.9% | 48.4% | – | – | – | – | – | – | – | – | – |
| Per employee | ||||||||||||
| Total employees | 20 | 24 | 79 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 48 | 46 |
| Revenue per employee | $59.00K | $1.21M | $60.76K | $0 | $0 | – | – | – | – | – | – | – |
| Gross profit per employee | $47.50K | $819.88K | $14.03K | $0 | $0 | – | – | – | – | – | – | – |
| Operating profit per employee | -$514.35K | -$850.33K | -$629.04K | -$1.53M | -$1.30M | -$1.21M | -$1.48M | -$1.35M | -$1.33M | -$869.11K | -$337.42K | – |
| Free cash flow per employee | -$404.95K | -$1.83M | -$287.65K | -$1.39M | -$1.25M | -$1.22M | -$1.20M | -$1.28M | -$1.10M | -$766.58K | -$351.06K | – |
| Growth | ||||||||||||
| Revenue 1Y growth | -95.9% | 502.9% | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | -95.2% | 1,675.9% | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | 49.6% | 58.9% | -70.4% | -17.7% | -8.1% | 18.4% | -9.8% | -1.4% | -52.8% | -2.0% | – | – |
| EBITDA 1Y growth | 40.3% | 66.2% | -69.5% | -18.4% | -9.5% | 19.1% | -8.4% | -1.2% | -54.4% | -1.8% | – | – |
| Diluted EPS 1Y growth | 100.0% | 83.3% | -100.0% | 25.0% | 66.7% | 29.4% | 19.0% | 22.2% | 3.6% | 0.00% | – | – |
| Operating cash flow 1Y growth | 81.6% | -94.1% | 13.8% | -11.3% | -1.6% | -2.4% | 6.3% | -17.7% | -41.6% | -2.4% | – | – |
| Free cash flow 1Y growth | 81.6% | -93.3% | 13.8% | -11.4% | -2.0% | -2.1% | 6.7% | -16.7% | -43.4% | 13.6% | – | – |
| CapEx 1Y growth | -52.8% | -54.3% | -11.5% | 35.1% | – | -100.0% | -61.3% | -48.8% | 550.0% | -98.1% | – | – |
| CapEx 3Y CAGR | -42.4% | -18.2% | – | 25.0% | -17.5% | – | 8.8% | -59.9% | – | – | – | – |
| CapEx 5Y CAGR | – | -4.6% | -7.7% | -17.3% | 13.3% | – | – | – | – | – | – | – |
| CapEx 10Y CAGR | -37.3% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 5.1% | -39.1% | -16.3% | -6.2% | 72.1% | -11.7% | -4.7% | -7.8% | 56.6% | – | – | – |
| Total assets 3Y CAGR | -18.8% | -21.8% | 10.6% | 12.6% | 13.1% | -8.1% | 11.2% | – | – | – | – | – |
| Total assets 5Y CAGR | -2.9% | -6.2% | 2.6% | 4.6% | 15.9% | – | – | – | – | – | – | – |
| Total equity 1Y growth | 35.2% | – | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.